() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Kaneh Bosm

Kaneh Bosm Biotechnology Provides Corporate Update

Kaneh Bosm BioTechnolgy Inc. (CSE:KBB) (“Kaneh Bosm” or the “Company”) is pleased to announce that it has closed the definitive agreement (the “Agreement”) with Marathon Global Inc. (“Marathon”) as previously announced on June 26, 2018 to acquire the remaining 50% of the issued and outstanding share capital of Marathon (the “Marathon Transaction”).
Read more

Kaneh Bosm to Expand Cultivation Footprint

Kaneh Bosm BioTechnology Inc. (CSE:KBB) (“Kaneh Bosm” or the “Company”) is pleased to announce that it has entered into a letter of intent to acquire a 100% interest of Cannabis Medical Group SAS (“CM Group”), which holds licences to cultivate, produce, hold, sell and export cannabis and its by-products.
Read more